2007—2009年我院口服抑酸剂应用分析  

Application of Oral Acid Inhibitors in Our Hospital from 2007 to 2009

作　　者：李牧[1] 封宇飞[1] 

机构地区：[1]卫生部北京医院药学部,北京100730

出　　处：《中国医院用药评价与分析》2011年第7期610-612,共3页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的:了解卫生部北京医院抑酸剂的应用情况及发展趋势,为临床合理用药提供参考。方法:采用药品金额排序法和限定日剂量法,对抑酸剂的品种、消耗量、销售金额、用药频度(DDDs)、限定日费用(DDC)进行综合分析、汇总。结果:我院近3年抑酸剂销售总金额呈逐年上升趋势,尤其是质子泵抑制剂销售金额及用药频度增加幅度更大,H2受体阻断剂的年销售额呈下降趋势,排序比值趋于1,同步性较好。结论:我院消化性溃疡患者抑酸剂应用合理,质子泵抑制剂因其安全、高效的特点现作为抑酸剂的首选,但H2受体阻断剂因其价格优势也被临床所认可。OBJECITVE： To probe into the status quo and tendency of the application of acid inhibitors in Beijing Hospital of Ministry of Health so as to provide reference for clinical rational use of acid inhibitors.METHODS： By means of consumption sum ranking and defined daily dose method,the categories,consumption amount,consumption sum,DDDs and DDC of acid inhibitors used in our hospital from 2007 to 2009 were statistically analyzed.RESULTS： The consumption sum of acid inhibitors in our hospital increased year by year from 2007 to 2009,especially for proton pump inhibitors which experienced a greater increase in both consumption sum and DDDs.The consumption sum of H2 receptor antagonist decreased year by year.The order ratio of drugs was approximately 1 over the three years with sound synchronicity.CONCLUSION： The application of acid inhibitors in our hospital of Ministry of Health is rational,and proton pump inhibitor is the best choice in the clinic because of its good safety and high performance.H2 receptor antagonist also gained clinical favor because of its advantage in price.

关 键 词：抑酸剂 用药频度 限定日费用 用药金额 

分 类 号：R975.6[医药卫生—药品]